Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shanchun Guo

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Cellular and Molecular Life Sciences : CMLS|June 10, 2024
Interaction of NF-κB and FOSL1 drives glioma stemnessVanajothi Ramar, Shanchun Guo, Breanna Hudson, et al.
Cellular Signalling|March 4, 2026
Rap1b promotes glioma growth and stemness via regulation of Notch1 and VEGFR2 signaling pathwaysRajveer Singh Sidhu, Vanajothi Ramar, Talib Safir, et al.
Cellular Signalling|May 15, 2010
Leptin upregulates VEGF in breast cancer via canonic and non-canonical signalling pathways and NFkappaB/HIF-1alpha activationRuben R Gonzalez-Perez, Yanbo Xu, Shanchun Guo, et al.
Frontiers in Pharmacology|December 31, 2020
TRPM7 Induces Tumorigenesis and Stemness Through Notch Activation in GliomaJingwei Wan, Alyssa Aihui Guo, Pendelton King, et al.
Oncotarget|December 22, 2017
Metabolism, pharmacokinetics, and bioavailability of ZB716, a Steroidal Selective Estrogen Receptor Downregulator (SERD)Changde Zhang, Shanchun Guo, Lin Yang, et al.
ACS Medicinal Chemistry Letters|February 20, 2018
Biocompatible Boron-Containing Prodrugs of Belinostat for the Potential Treatment of Solid TumorsShilong Zheng, Shanchun Guo, Qiu Zhong, et al.
Bioorganic & Medicinal Chemistry Letters|June 13, 2020
Development of a bioavailable boron-containing PI-103 Bioisostere, PI-103BELan Luo, Qiu Zhong, Shanchun Guo, et al.
Cytokine & Growth Factor Reviews|August 2, 2011
CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implicationsMingli Liu, Shanchun Guo, Jacqueline M Hibbert, et al.
Medicine|August 10, 2022
The efficacy and safety of immune checkpoint inhibitors in metastatic castration-resistant prostate cancer: A systematic review and meta-analysisXing-Hui Wang, Zhi-Qiang Wang, Zhen-Yu Mu, et al.
Cellular and Molecular Life Sciences : CMLS|August 29, 2023
TRPM7 transactivates the FOSL1 gene through STAT3 and enhances glioma stemnessShanchun Guo, Vanajothi Ramar, Alyssa A Guo, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Cellular and Molecular Life Sciences : CMLS|June 10, 2024
Interaction of NF-κB and FOSL1 drives glioma stemnessVanajothi Ramar, Shanchun Guo, Breanna Hudson, et al.
Cellular Signalling|March 4, 2026
Rap1b promotes glioma growth and stemness via regulation of Notch1 and VEGFR2 signaling pathwaysRajveer Singh Sidhu, Vanajothi Ramar, Talib Safir, et al.
Cellular Signalling|May 15, 2010
Leptin upregulates VEGF in breast cancer via canonic and non-canonical signalling pathways and NFkappaB/HIF-1alpha activationRuben R Gonzalez-Perez, Yanbo Xu, Shanchun Guo, et al.
Frontiers in Pharmacology|December 31, 2020
TRPM7 Induces Tumorigenesis and Stemness Through Notch Activation in GliomaJingwei Wan, Alyssa Aihui Guo, Pendelton King, et al.
Oncotarget|December 22, 2017
Metabolism, pharmacokinetics, and bioavailability of ZB716, a Steroidal Selective Estrogen Receptor Downregulator (SERD)Changde Zhang, Shanchun Guo, Lin Yang, et al.
ACS Medicinal Chemistry Letters|February 20, 2018
Biocompatible Boron-Containing Prodrugs of Belinostat for the Potential Treatment of Solid TumorsShilong Zheng, Shanchun Guo, Qiu Zhong, et al.
Bioorganic & Medicinal Chemistry Letters|June 13, 2020
Development of a bioavailable boron-containing PI-103 Bioisostere, PI-103BELan Luo, Qiu Zhong, Shanchun Guo, et al.
Cytokine & Growth Factor Reviews|August 2, 2011
CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implicationsMingli Liu, Shanchun Guo, Jacqueline M Hibbert, et al.
Medicine|August 10, 2022
The efficacy and safety of immune checkpoint inhibitors in metastatic castration-resistant prostate cancer: A systematic review and meta-analysisXing-Hui Wang, Zhi-Qiang Wang, Zhen-Yu Mu, et al.
Cellular and Molecular Life Sciences : CMLS|August 29, 2023
TRPM7 transactivates the FOSL1 gene through STAT3 and enhances glioma stemnessShanchun Guo, Vanajothi Ramar, Alyssa A Guo, et al.
Pageof 7